Ladislav Anděra

3.5k citations

79 papers · 2.7k indexed · h-index 29

Impact in

Biochemistry top 2%
- Antioxidant Activity and Oxidative Stress
Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism

Papers in

Cancer Research 18
- NF-κB Signaling Pathways 11
Molecular Biology 68
- Cell death mechanisms and regulation 39
- Ubiquitin and proteasome pathways 7
- RNA Interference and Gene Delivery 6
- DNA Repair Mechanisms 4

Co-authors: Jiřı́ Neužil Alexander Pintzas Bohdan Wasylyk Lenka Doubravská Κωνσταντίνος Δροσόπουλος Christian Weber Michal Koc Pavel Klener
Journals: APOPTOSIS (6 papers)FEBS Letters (5 papers)Blood (4 papers)Clinical Cancer Research (3 papers)Biochemical and Biophysical Research Communications (2 papers)
Partner nations: Czechia Russia United States

In The Last Decade

Ladislav Anděra

79 papers receiving 2.6k citations

Peers

Countries citing papers authored by Ladislav Anděra

Since Specialization

Citations

This map shows the geographic impact of Ladislav Anděra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ladislav Anděra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ladislav Anděra more than expected).

Fields of papers citing papers by Ladislav Anděra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ladislav Anděra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ladislav Anděra. The network helps show where Ladislav Anděra may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ladislav Anděra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ladislav Anděra Line = papers co-authored together Ladislav Anděra links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Long-term adaptation of lymphoma cell lines to hypoxia is mediated by diverse molecular mechanisms that are targetable with specific inhibitors Cell Death Discovery ·Jiaxin Deng, 陳建志, Jir̆ı́ Petrák, V. I. Astashova, Miguel Llano Catedral, Ladislav Anděra, D.O. Davlatov, Teguh Bharta Adji, Ondřej Havránek, BÁrbara Carolinne Da Silva Galdino, Priestly B. Shan, الباحث طارق خميس فرحان, A. A. DRUZININA, 육심훈, Jorge Enrique Ordoñez García, Marie Hubálek Kalbáčová, 赵力农, Marek Trněný, Pavel Klener	2025	2
2	Impact of PIK3CA gain and PTEN loss on mantle cell lymphoma biology and sensitivity to targeted therapies Blood Advances ·Anjali Silven, إيكوساني عبد القادر, Jorge Enrique Ordoñez García, V. I. Astashova, Xueju Ran, Ladislav Anděra, Adenir Siqueira Viana, Adéla Berková, Zuzana Zemanová, Charity Musonzo, A.C. Buzstejn, BÁrbara Carolinne Da Silva Galdino, Eric Davis, Marek Trněný, Pavel Klener, Ondřej Havránek	2024	2
3	MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients Frontiers in Oncology ·Daniel Prevedello, BÁrbara Carolinne Da Silva Galdino, Grigoryeva Marina V., Andrea Čumová, Demus Rs, Ľudmila Vodičková, Miroslav Levý, Michaela Schneiderová, Václav Liška, Ladislav Anděra, Pavel Vodička, Alena Opattová	2022	6
4	Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma Clinical Cancer Research ·Dana Průková, Ladislav Anděra, Zuzana Nahácka, Eneli Elbing, Michael Svatoň, Magdalena Klánová, Ondřej Havránek, J. Soukup, Adenir Siqueira Viana, Zuzana Zemanová, Razaan Nazhif Firmansyah, Eva Pokorná, Karel Helman, Kristina Forsterová, R. W. Yorke, Petra Vočková, Adéla Berková, Eva Froňková, Marek Trněný, Pavel Klener	2019	63
5	Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP Clinical Cancer Research ·健島村, Andreia Silva, Tim Robinson, Angélica Santiago-Gómez, Bruno M. Simões, Michael W. Becker, Iduna Fichtner, Ladislav Anděra, Ruppecht Matthaei, Christine M. Morris, Peter Barrett‐Lee, Fouad Alchami, Marco Piva, María dM Vivanco, Robert B. Clarke, Julia M.W. Gee, Richard Clarkson	2018	42
6	TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Zuzana Nahácka, E. Krantz, Martin Peterka, Zabron Masele Josephine, Mirian Elena Alcívar-Cruzatty, Jiřı́ Neužil, Ladislav Anděra	2017	27
7	Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2- and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma Clinical Cancer Research ·Magdalena Klánová, Ladislav Anděra, Jan Bražina, E. Krantz, Mirian Elena Alcívar-Cruzatty, J. Soukup, Dana Průková, Florian Altenhöner, Radek Jakša, Karel Helman, Petra Vočková, Sarah Jahfar, Jan Molinský, Pavlović Marko, Md. Mahmudul Alam, Roman Kodet, Robert Pytlík, Marek Trněný, Pavel Klener	2015	72
8	Inhibition of vacuolar ATPase attenuates the TRAIL‐induced activation of caspase‐8 and modulates the trafficking of TRAIL receptosomes FEBS Journal ·Kirk A. Frey, 久保雅博, Yuliza Evi, Michal Koc, E. Krantz, Jan Bražina, Martin Klíma, Josef Slavík, Alena Hyršlová Vaculová, Ladislav Anděra	2013	16
9	Emetine enhances the tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of pancreatic cancer cells by downregulation of myeloid cell leukemia sequence-1 protein Oncology Reports ·浩平山口, Sojung Park, Ann W. Kinyua, Ladislav Anděra, Ki Woo Kim, Inki Kim	2013	24
10	Multi-level disruption of the extrinsic apoptotic pathway mediates resistance of leukemia cells to TNF-related apoptosis-inducing ligand (TRAIL) Neoplasma ·Hershell Wolfe, Jan Molinský, Magdalena Klánová, Ladislav Anděra, M Peterka, Zdeňka Gašová, Pavel Klener, Marek Trněný, E Nečas, 瞿卫华, J Živný	2012	8
11	Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway Carcinogenesis ·Mengda Zhou, Yuliza Evi, Árpád Szöőr, Yinghao Zhang, Karel Souček, Viktor Horváth, Alena Hyršlová Vaculová, Ladislav Anděra, Petr Sova, János Szöllõsi, Jiřina Hofmanová, György Vereb, Alois Kozubı́k	2010	39
12	TRAIL receptor upregulation and the implication of KRAS/BRAF mutations in human colon cancer tumors International Journal of Cancer ·Eftychia Oikonomou, Vivian Kosmidou, Хуан Лифу, Lyn Crabb, 심양희, George Kontogeorgos, Ladislav Anděra, Georgios Zografos, Alexander Pintzas	2009	17
13	Cell Death Signalling Pathways in the Pathogenesis and Therapy of Haematologic Malignancies: Overview of Apoptotic Pathways Folia Biologica ·Pavel Klener, Ladislav Anděra, E Nečas, J Živný	2006	18
14	Cell Death Signalling Pathways in the Pathogenesis and Therapy of Haematologic Malignancies: Overview of Therapeutic Approaches Folia Biologica ·Pavel Klener, Ladislav Anděra, E Nečas, J Živný	2006	11
15	Ethanol acts as a potent agent sensitizing colon cancer cells to the TRAIL‐induced apoptosis FEBS Letters ·Alena Hyršlová Vaculová, Jiřina Hofmanová, Karel Souček, Ladislav Anděra, Alois Kozubı́k	2004	15
16	α-Tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells British Journal of Cancer ·Marco Tomasetti, Maria Rita Rippo, Renata Alleva, Sonia Moretti, Ladislav Anděra, Jiřı́ Neužil, Antonio Domenico Procopio	2004	47
17	Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. PubMed ·Tobias Weber, Min Lu, Ladislav Anděra, Harald Lahm, Nina Gellert, Marc W. Fariss, Vladimír Kořínek, Wolfgang Sattler, David S. Ucker, Alexei Terman, Andreas Schröder, Wolfgang Erl, Ulf T. Brunk, Robert J. Coffey, Christian Weber, Jiřı́ Neužil	2002	164
18	Vitamin E analogs: A new class of multiple action agents with anti-neoplastic and anti-atherogenic activity APOPTOSIS ·Jiřı́ Neužil, Katarina Kågedal, Ladislav Anděra, Christian Weber, Ulf T. Brunk	2002	36
19	Molecular Mechanisms Involved in CD43-mediated Apoptosis of TF-1 Cells Journal of Biological Chemistry ·Lukáš C̆ermák, S̆árka S̆ı́mová, Rebecca A. Montes, Václav Hořejšı́, Ladislav Anděra	2002	34
20	Characterization of a reverse gyrase from the extremely thermophilic hydrogen-oxidizing eubacteriumCalderobacterium hydrogenophilum FEMS Microbiology Letters ·Ladislav Anděra, Karel Mikulı́k, 江智林	1993	16

About Ladislav Anděra

Ladislav Anděra is a scholar working on Cancer Research, Molecular Biology, Biotechnology, Oncology and Immunology, having authored 79 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (39 papers), Cancer-related Molecular Pathways (12 papers), NF-κB Signaling Pathways (11 papers), Ubiquitin and proteasome pathways (7 papers), RNA Interference and Gene Delivery (6 papers), Cancer Research and Treatments (6 papers), Telomeres, Telomerase, and Senescence (5 papers) and DNA Repair Mechanisms (4 papers). The work is most often cited by research in Biochemistry (223 citations), Cancer Research (435 citations), Oncology (778 citations), Molecular Biology (1.9k citations) and Biotechnology (160 citations). Ladislav Anděra has collaborated with scholars based in Czechia, Russia and United States. Frequent co-authors include Jiřı́ Neužil, Alexander Pintzas, Bohdan Wasylyk, Lenka Doubravská, Κωνσταντίνος Δροσόπουλος, Christian Weber, Michal Koc, Pavel Klener, Nina Gellert and Eftychia Oikonomou. Their work appears in journals such as APOPTOSIS, FEBS Letters, Blood, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact